Yahoo India Web Search

Search results

  1. 1 hour ago · Eli Lilly & Co., a global leader in pharmaceuticals, has announced the acquisition of Morphic Holding Inc., a US-based biotech company specializing in treatments for gut diseases. This $3.2 billion deal marks a strategic investment for Lilly, aiming to strengthen its experimental pipeline and expand its presence in immunology.

  2. 1 day ago · Acquisition to expand Lilly's immunology pipeline with oral integrin therapies . INDIANAPOLIS and WALTHAM, Mass., July 8, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF) today announced a definitive agreement for Lilly to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases.

  3. 1 day ago · Lilly reported revenues of $8.77 billion in the last reported quarter, representing a year-over-year change of +26%. EPS of $2.58 for the same period compares with $1.62 a year ago. Compared to ...

  4. 3 days ago · Latest Eli Lilly and Co (LLY:NYQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

  5. People also ask

  6. 4 days ago · Get a real-time Eli Lilly and Company (LLY) stock price quote with breaking news, financials, statistics, charts and more.

  7. 8 hours ago · Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes ...

  8. 5 days ago · Company profile for Eli Lilly and Company (LLY) with a description, list of executives, contact details and other key facts.

  1. People also search for